HC Wainwright Maintains Bullish Outlook on Eton Pharmaceuticals Growth Strategy Deutsche Bank Aktiengesellschaft DB Shows Resilient Core Business Despite Market Volatility Astera Labs Shares Decline as Market Eyes Potential Sector Headwinds Trump Mobile Investigates Potential Data Exposure Affecting Thousands of Prospective Customers EasyJet Assures Summer Flight Schedule Unaffected by Jet Fuel Supply Concerns Deepa Jewellers and Cotec Healthcare Secure SEBI Approval for Initial Public Offerings Birchtech Corp BCHT Q1 2026 Earnings EPS Falls Short of Estimates Stock Slips RIGL Q1 2026 Earnings EPS Misses Estimates by a Wide Margin Stock Declines After Surprise FCEL Q1 2026 Earnings EPS Surprises to the Upside Shares Dip Despite Narrowing Losses Paramount Gold Nevada Corp Q1 2026 Earnings Significant EPS Miss Highlights PreRevenue Stage Challenges Porch Group Q1 2026 Earnings EPS Surprises with 47 Beat Amid Revenue Discretion Outset Medical Inc OM Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges JNJ Shows Resilient Rise Johnson Johnson Edges Higher Amid Defensive Appeal JDcom Stock Slips Amid ProfitTaking and Sector Headwinds Key Support Tested Hennessy Capital Investment Corp VIII Units HCICU Hold Steady at 1004 as Market Awaits Business Combination Progress PubMatic Inc PUBM Shows Resilience Price Action and Key Levels After 147 Gain Century Casinos CNTY Slips 108 as Stock Hovers Near Key Support Rogers Communications RCI Gains 148 as Shares Approach Resistance at 3905 Carlyle Credit Income Fund Series D Preferred Shares CCID Hold Steady at 2535 Enova International ENVA Declines 175 as Stock Holds Between Key Support and Resistance Crocs Inc CROX Surges Over 5 as Shares Test Key Resistance Levels GSI Technology GSIT Surges 474 as Momentum Builds Near Key Resistance Abacus Global Management ABX Consolidates Near Support Following Modest Decline Tech Sector Uplifts US Equities Oil Prices Slide on Prospects of Iran Nuclear Deal MKTW Q1 2026 Earnings Deep EPS Miss Overshadowed by Modest Stock Recovery Nektar Therapeutics NKTR Fades 287 as Biotech Stock Tests Key Support Levels